Salta al contenuto principale
Passa alla visualizzazione normale.

SALVATORE PETTA

Pubblicazioni

Data Titolo Tipologia Scheda
2024 IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids Articolo in rivista Vai
2024 ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization Articolo in rivista Vai
2024 Quantitative Evaluation by Digital Pathology of Immunohistochemical Expression of CK7, CK19, and EpCAM in Advanced Stages of NASH Articolo in rivista Vai
2023 A global research priority agenda to advance public health responses to fatty liver disease Articolo in rivista Vai
2023 Heart rate variability is associated with disease severity and portal hypertension in cirrhosis Articolo in rivista Vai
2023 Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women Articolo in rivista Vai
2023 Corrigendum to 'Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)' Nutrition, Metabolism and Cardiovascular diseases volume 32 issue 1 (2022) 1-16 Nota o commento Vai
2023 Corrigendum to "Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)" [Dig Liver Dis 54 (2022) 170-182] Nota o commento Vai
2023 Accuracy, Reliability, and Comprehensiveness of ChatGPT-Generated Medical Responses for Patients With Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2023 Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease Articolo in rivista Vai
2023 Glycemic control, body weight reduction, or glucose-lowering therapy in diabetic patients: What is better for the liver? Recensione in rivista Vai
2023 Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes Articolo in rivista Vai
2023 Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2023 Measuring the impact of the updated Steatotic liver disease nomenclature and definition Nota o commento Vai
2023 Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis Articolo in rivista Vai
2023 Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin-22, interleukin-6 and interleukin-1Ra concentrations according to portal hypertension and disease severity Articolo in rivista Vai
2023 Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease Articolo in rivista Vai
2023 Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study Articolo in rivista Vai
2023 A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies Articolo in rivista Vai
2023 Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study Articolo in rivista Vai
2023 Individual and population screening of varices needing treatment by a simple, safe and accurate test Articolo in rivista Vai
2023 Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol Articolo in rivista Vai
2023 MAFLD: a multisystem disease Recensione in rivista Vai
2023 Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study Articolo in rivista Vai
2022 Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) Articolo in rivista Vai
2022 Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators Articolo in rivista Vai
2022 Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis Articolo in rivista Vai
2022 Advancing the global public health agenda for NAFLD: a consensus statement Articolo in rivista Vai
2022 Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) Articolo in rivista Vai
2022 PSD3 downregulation confers protection against fatty liver disease Articolo in rivista Vai
2022 Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients Articolo in rivista Vai
2022 Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance Articolo in rivista Vai
2022 Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trial Articolo in rivista Vai
2022 A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2022 Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach? Articolo in rivista Vai
2022 A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2022 Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development Articolo in rivista Vai
2022 "Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV" Articolo in rivista Vai
2022 Comparison of screening strategies with two new tests to score and diagnose varices needing treatment Articolo in rivista Vai
2022 Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis Articolo in rivista Vai
2022 Reply to: Correspondence on "EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update" Lettera Vai
2022 NAFLD/NASH Nota o commento Vai
2022 Rare ATG7 genetic variants predispose patients to severe fatty liver disease Articolo in rivista Vai
2022 Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease Articolo in rivista Vai
2022 Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation Review essay (rassegna critica) Vai
2022 RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices Articolo in rivista Vai
2022 Global multi-stakeholder endorsement of the MAFLD definition Lettera Vai
2022 AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD Articolo in rivista Vai
2022 Geographical similarity and differences in the burden and genetic predisposition of NAFLD Review essay (rassegna critica) Vai
2022 Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease Articolo in rivista Vai
2021 Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease Articolo in rivista Vai
2021 THE ROLE OF TRANSIENT ELASTOGRAPHY IN NAFLD Capitolo o Saggio Vai
2021 Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population Articolo in rivista Vai
2021 Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography Articolo in rivista Vai
2021 Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis Articolo in rivista Vai
2021 Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis Articolo in rivista Vai
2021 Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: A web-based survey Articolo in rivista Vai
2021 Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study Articolo in rivista Vai
2021 Naïve hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: A prospective study Articolo in rivista Vai
2021 Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2 Articolo in rivista Vai
2021 Mistranslation Drives Alterations in Protein Levels and the Effects of a Synonymous Variant at the Fibroblast Growth Factor 21 Locus Articolo in rivista Vai
2021 Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease Articolo in rivista Vai
2021 Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes Articolo in rivista Vai
2021 Italian association for the study of the liver position statement on SARS-CoV2 vaccination Articolo in rivista Vai
2021 Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2021 Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) Articolo in rivista Vai
2021 Is there an ‘ideal’ diet for patients with NAFLD? Articolo in rivista Vai
2021 Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores Articolo in rivista Vai
2021 EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update Articolo in rivista Vai
2021 Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN) Articolo in rivista Vai
2021 Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort Articolo in rivista Vai
2021 Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis Articolo in rivista Vai
2021 First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials Articolo in rivista Vai
2021 Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment Articolo in rivista Vai
2021 Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort Articolo in rivista Vai
2020 FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage Articolo in rivista Vai
2020 Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease Articolo in rivista Vai
2020 Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patients Articolo in rivista Vai
2020 qFIBS: A Novel Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis Articolo in rivista Vai
2020 Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation Articolo in rivista Vai
2020 Optimization of hepatitis C virus screening strategies by birth cohort in Italy Articolo in rivista Vai
2020 Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study Articolo in rivista Vai
2020 Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis Articolo in rivista Vai
2020 IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION Abstract in atti di convegno pubblicato in rivista Vai
2020 Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2020 Lifestyle changes for the treatment of nonalcoholic fatty liver disease-a 2015-19 update Review essay (rassegna critica) Vai
2020 Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease Articolo in rivista Vai
2020 MAFLD vs NAFLD: Let the contest begin! Nota o commento Vai
2020 PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2020 AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement Review essay (rassegna critica) Vai
2020 Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver Articolo in rivista Vai
2020 Outcomes of Liver Transplant for Adults With Wilson’s Disease Articolo in rivista Vai
2020 Prevalence, predictors, and severity of lean nonalcoholic fatty liver disease in patients living with human immunodeficiency virus Articolo in rivista Vai
2020 Genetic variants in the MTHFR are not associated with fatty liver disease Articolo in rivista Vai
2020 Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP) Articolo in rivista Vai
2020 Machine Perfusions in Liver Transplantation: The Evidence-Based Position Paper of the Italian Society of Organ and Tissue Transplantation Articolo in rivista Vai
2020 PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD Articolo in rivista Vai
2020 Extrahepatic Manifestations of Chronic Viral C Hepatitis Review essay (rassegna critica) Vai
2020 Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD Articolo in rivista Vai
2020 Identification of patients with advanced fibrosis due to nonalcoholic fatty liver disease: Considerations for best practice Review essay (rassegna critica) Vai
2020 The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease Articolo in rivista Vai
2020 Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆ Articolo in rivista Vai
2020 Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2020 Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy Articolo in rivista Vai
2020 Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis Articolo in rivista Vai
2020 Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: How to manage in clinical practice Review essay (rassegna critica) Vai
2020 Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study Articolo in rivista Vai
2020 Biochemical biomarkers of NAFLD/NASH Capitolo o Saggio Vai
2020 The relevance of noninvasive tools to assess fibrosis in non-alcoholic fatty liver disease Articolo in rivista Vai
2019 Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data Articolo in rivista Vai
2019 Current epidemiology of HCV in Sicily: the RESIST-HCV model Abstract in atti di convegno pubblicato in rivista Vai
2019 Liver stiffness quantification in patients with non-alcoholic steatohepatitis: comparison of shear wave elastography and transient elastography with liver biopsy correlation Abstract in atti di convegno pubblicato in rivista Vai
2019 Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals Articolo in rivista Vai
2019 Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis Articolo in rivista Vai
2019 Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients Abstract in atti di convegno pubblicato in rivista Vai
2019 Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation Articolo in rivista Vai
2019 Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease Articolo in rivista Vai
2019 Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Articolo in rivista Vai
2019 PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients Articolo in rivista Vai
2019 Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity Articolo in rivista Vai
2019 Role of myeloid-epithelial-reproductive tyrosine kinase and macrophage polarization in the progression of atherosclerotic lesions associated with nonalcoholic fatty liver disease Articolo in rivista Vai
2019 Pharmacological therapy of non-alcoholic fatty liver disease: What drugs are available now and future perspectives Articolo in rivista Vai
2019 Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) Articolo in rivista Vai
2019 The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: Screening issue and future perspectives Articolo in rivista Vai
2019 Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy Articolo in rivista Vai
2019 Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience Articolo in rivista Vai
2019 Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis Articolo in rivista Vai
2019 Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients with Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2019 Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons with HIV infection and Compensated Advanced Chronic Liver Disease Articolo in rivista Vai
2019 Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients Articolo in rivista Vai
2019 Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) Articolo in rivista Vai
2019 AISF position paper on HCV in immunocompromised patients Articolo in rivista Vai
2019 IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION Abstract in atti di convegno pubblicato in rivista Vai
2019 Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2018 HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals Articolo in rivista Vai
2018 Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver Articolo in rivista Vai
2018 Is global elimination of HCV realistic? Articolo in rivista Vai
2018 Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. Articolo in rivista Vai
2018 Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study Articolo in rivista Vai
2018 Liver and statins: a critical appraisal of the evidence Articolo in rivista Vai
2018 L’insulino-resistenza è il principale fattore indipendente correlato con l’aumentato rischio metabolico nelle donne affette da PCOS eedings Vai
2018 Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents Articolo in rivista Vai
2018 Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents Articolo in rivista Vai
2018 Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population Articolo in rivista Vai
2018 Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) Articolo in rivista Vai
2018 Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 Articolo in rivista Vai
2018 The course of oesophagogastric varices in patients with cirrhosis after DAA-induced HCV clearance Abstract in atti di convegno pubblicato in rivista Vai
2018 Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis Articolo in rivista Vai
2018 Expert opinion on managing chronic HCV in patients with cardiovascular disease Articolo in rivista Vai
2018 An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers Articolo in rivista Vai
2018 Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis Articolo in rivista Vai
2018 Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort Poster pubblicato in rivista Vai
2018 A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B Articolo in rivista Vai
2018 Antidiabetic drugs in NAFLD: The accomplishment of two goals at once? Articolo in rivista Vai
2018 Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease Articolo in rivista Vai
2018 Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) Nota o commento Vai
2018 Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) Articolo in rivista Vai
2018 Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis Articolo in rivista Vai
2017 Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease Articolo in rivista Vai
2017 Emerging Increase in the prevalence and severity of nonalcoholic fatty liver disease: epidemiological study from general Mediterranean population Abstract in atti di convegno pubblicato in rivista Vai
2017 Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis Articolo in rivista Vai
2017 A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma Articolo in rivista Vai
2017 Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2017 Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity Articolo in rivista Vai
2017 Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study Articolo in rivista Vai
2017 Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values Articolo in rivista Vai
2017 Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel Articolo in rivista Vai
2017 Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease Articolo in rivista Vai
2017 Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study Articolo in rivista Vai
2017 Hepatitis C virus and cardiovascular: A review Articolo in rivista Vai
2017 Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD Articolo in rivista Vai
2017 Evidence-Based Medicine and the Problem of Healthy Volunteers Articolo in rivista Vai
2017 Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network Articolo in rivista Vai
2017 Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study Articolo in rivista Vai
2017 Can we prevent and modify cardiometabolic disorders by controlling HCV infection? Articolo in rivista Vai
2017 Coffee and tea breaks for liver health Articolo in rivista Vai
2017 Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study Articolo in rivista Vai
2017 The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B Articolo in rivista Vai
2017 Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma Articolo in rivista Vai
2017 AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions Articolo in rivista Vai
2017 Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS Articolo in rivista Vai
2017 Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease Articolo in rivista Vai
2017 Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter Articolo in rivista Vai
2017 Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon Articolo in rivista Vai
2017 Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies Articolo in rivista Vai
2017 MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals Articolo in rivista Vai
2017 Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study Articolo in rivista Vai
2017 Reply Lettera Vai
2017 Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV Articolo in rivista Vai
2016 Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies Articolo in rivista Vai
2016 The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent Articolo in rivista Vai
2016 Diet, Weight Loss, and Liver Health in NAFLD: Pathophysiology, Evidence and Practice Review essay (rassegna critica) Vai
2016 Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model Articolo in rivista Vai
2016 The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease Articolo in rivista Vai
2016 The cheating liver: imaging of focal steatosis and fatty sparing Articolo in rivista Vai
2016 TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2016 HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels Articolo in rivista Vai
2016 Renin-angiotensin system inhibitors, type 2 diabetes and fibrosis progression: An observational study in patients with nonalcoholic fatty liver disease Articolo in rivista Vai
2016 Pathophysiology of non alcoholic fatty liver disease Articolo in rivista Vai
2016 From current status to optimization of HCV treatment: Recommendations from an expert panel Articolo in rivista Vai
2016 IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection Articolo in rivista Vai
2016 Non-Invasive Assessment of Liver Injury in Non-Alcoholic Fatty Liver Disease: A Review of Literature Articolo in rivista Vai
2016 Reply to 'Genetic and clinical data reinforce the role of GAS6 and TAM receptors in liver fibrosis' Lettera Vai
2016 Reply Lettera Vai
2016 Reply Lettera Vai
2016 A "systems medicine" approach to the study of non-alcoholic fatty liver disease Articolo in rivista Vai
2015 The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity Abstract in rivista Vai
2015 Statin use and non-alcoholic steatohepatitis in at risk individuals Articolo in rivista Vai
2015 Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease Articolo in rivista Vai
2015 Current and future HCV therapy: Do we still need other anti-HCV drugs? Articolo in rivista Vai
2015 The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease Articolo in rivista Vai
2015 The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. Articolo in rivista Vai
2015 The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis Articolo in rivista Vai
2015 PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C Articolo in rivista Vai
2015 Genetic background in nonalcoholic fatty liver disease: A comprehensive review Articolo in rivista Vai
2015 Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis Articolo in rivista Vai
2015 The Hepatic Expression of Vitamin D Receptor is Inversely Associated with the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients. Articolo in rivista Vai
2015 Sorafenib for hepatocellular carcinoma: From randomized controlled trials to clinical practice Articolo in rivista Vai
2015 Comparison of Histochemical Staining Methods and Correlation with Transient Elastography in Acute Hepatitis. Articolo in rivista Vai
2015 MERTK rs4374383 polymorphism affects the severity of fibrosis in nonalcoholic fatty liver disease Articolo in rivista Vai
2015 Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease Articolo in rivista Vai
2015 The rs2294918 E434K variant modulates PNPLA3 expression and liver damage Articolo in rivista Vai
2015 Reply Lettera Vai
2015 Reply Lettera Vai
2015 Epicardial fat in patients with non-alcoholic fatty liver disease Lettera Vai
2015 Response to Dr. Sertoglu and colleagues Lettera Vai
2015 Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis Articolo in rivista Vai
2014 Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease Articolo in rivista Vai
2014 Reply to: “Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients” Recensione in rivista Vai
2014 Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2014 Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women Abstract in rivista Vai
2014 Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2014 Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2014 Reply to: Is industrial fructose just a marker of an unhealthy dietary pattern? Recensione in rivista Vai
2014 Triple therapy with first-generation Protease Inhibitors for patients with genotype 1 chronic hepatitis C: Recommendations of the Italian Association for the Study of the Liver (AISF) Articolo in rivista Vai
2013 Cardiovascular diseases and HCV infection: a simple association or more? Articolo in rivista Vai
2013 Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients Articolo in rivista Vai
2013 NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis. Articolo in rivista Vai
2013 Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2013 Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease Articolo in rivista Vai
2013 Reply to: "IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients". Articolo in rivista Vai
2013 Metabolic Factors and Chronic Hepatitis C: A Complex Interplay Articolo in rivista Vai
2013 Chemoprevention for hepatocellular carcinoma: the role of statins Articolo in rivista Vai
2013 Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients eedings Vai
2013 PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease Articolo in rivista Vai
2013 Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Articolo in rivista Vai
2013 Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients Articolo in rivista Vai
2013 Insulin-like growth factor-I, inflammatory proteins, and fibrosis in subjects with nonalcoholic fatty liver disease Articolo in rivista Vai
2013 Update on treatment strategies in patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2013 Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma. Articolo in rivista Vai
2013 Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance Articolo in rivista Vai
2013 Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients? Articolo in rivista Vai
2013 Non invasive indexes for the assessment of patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2013 High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2013 How to optimize HCV therapy in genotype 1 patients: predictors of response. Articolo in rivista Vai
2013 Reply. Articolo in rivista Vai
2012 Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection. Articolo in rivista Vai
2012 Diagnostic and therapeutical role of vitamin D in chronic hepatitis C virus infection. Articolo in rivista Vai
2012 Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients. Articolo in rivista Vai
2012 Reproductive status is associated with the severity of fibrosis in women with hepatitis C Articolo in rivista Vai
2012 Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients. Articolo in rivista Vai
2012 Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C Articolo in rivista Vai
2012 Iperuricemia: significato clinico e nuove prospettive di trattamento eedings Vai
2012 Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. Articolo in rivista Vai
2012 Chronic hepatitis C and atherosclerosis: A complex pathogenic puzzle. Articolo in rivista Vai
2012 IL28B and PNPLA3 Polymorphisms Affect Histological Liver Damage in Patients with Non-alcoholic Fatty Liver Disease. Articolo in rivista Vai
2012 Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. Articolo in rivista Vai
2012 Assessment by Fibroscan of fibrosis in nonalcoholic fatty liver disease: XL versus M probe? Articolo in rivista Vai
2012 Insulin resistance and diabetes mellitus in patients with chronic hepatitis C: spectators or actors? Articolo in rivista Vai
2012 Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2012 Methylenetetrahydrofolate reductase homozygosis and low-density lipoproteins in patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2012 Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis. Articolo in rivista Vai
2012 herapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat? Articolo in rivista Vai
2011 LIPIDOMICS OF FATTY LIVER IN NAFLD AND HCV INFECTION: LIVER SPHYNGOLIPIDS AND FATTY ACIDS eedings Vai
2011 TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. Articolo in rivista Vai
2011 Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Articolo in rivista Vai
2011 Hyperuricemia in non-alcoholic fatty liver disease: authors' reply. Articolo in rivista Vai
2011 Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. Articolo in rivista Vai
2011 Optimal therapy in hepatitis C virus genotypes 2 and 3 patients. Articolo in rivista Vai
2011 High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis Articolo in rivista Vai
2011 Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Articolo in rivista Vai
2011 Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. Articolo in rivista Vai
2011 Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. Articolo in rivista Vai
2011 Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. Articolo in rivista Vai
2011 FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT Abstract in rivista Vai
2011 LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C Abstract in rivista Vai
2011 Liver follicular helper T-cells in chronic hepatitis C Abstract in rivista Vai
2011 Is liver stiffness measurement unreliable in obese patients? authors' reply. Articolo in rivista Vai
2010 Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. Articolo in rivista Vai
2010 HEPATIC STEATOSIS IS ASSOCIATED WITH SEVERE FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B eedings Vai
2010 Replay Articolo in rivista Vai
2010 LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C Abstract in rivista Vai
2010 Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C Articolo in rivista Vai
2010 Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Articolo in rivista Vai
2010 FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT Abstract in rivista Vai
2010 Reply Articolo in rivista Vai
2009 Reply Articolo in rivista Vai
2009 Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. Articolo in rivista Vai
2009 HEPATITIS C AND DIABETES: THE INEVITABLE COINCIDENCE? Articolo in rivista Vai
2009 Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection Articolo in rivista Vai
2009 Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the future. Articolo in rivista Vai
2009 Reply Articolo in rivista Vai
2009 Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis Articolo in rivista Vai
2009 Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection Articolo in rivista Vai
2009 Non-alcoholic fatty liver disease pathogenesis: The present and the future Articolo in rivista Vai
2008 Serum BLYS/BAFF levels in acute hepatitis C predict clinical outcome eedings Vai
2008 Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C. Articolo in rivista Vai
2008 751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS Articolo in rivista Vai
2008 Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. Articolo in rivista Vai
2008 Retinol-binding protein 4 (RBP4) : a new marker of G1 HCV-induced steatosis Articolo in rivista Vai
2008 Metformina e pioglitazone in soggetti affetti da diabete mellito tipo 2 con steatosi epatica eedings Vai
2008 Hepatic expression of cyclooxygenase-2 in non alcoholic fatty liver disease eedings Vai
2008 Reply Articolo in rivista Vai
2008 Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Articolo in rivista Vai
2008 Hepatic expression of cycloxygenase-2 in non-alcoholic fatty liver disease eedings Vai
2007 INSULIN RESISTANCE AND SEVERITY OF FIBROSIS IN HCV GENOTYPE 1 CHRONIC HEPATITIS. eedings Vai
2007 The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. Articolo in rivista Vai
2007 Virus-related insulin resistance in HCV genotype 1 chronic hepatitis C : a major disease modifier eedings Vai
2007 STORIA NATURALE DELLA CIRROSI EPATICA Capitolo o Saggio Vai
2005 Il carcinoma dell'esofago Articolo in rivista Vai